Literature DB >> 14759805

Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes.

Françoise Carlotti1, Merlijn Bazuine, Tuija Kekarainen, Jurgen Seppen, Philippe Pognonec, J Antonie Maassen, Rob C Hoeben.   

Abstract

Obesity is associated with many serious afflictions such as cardiovascular disease, cancer, and diabetes. One of the main cellular systems used to study the underlying physiological and biological processes is the 3T3-L1 preadipocyte differentiation model. However, studies on 3T3-L1 adipocytes are hampered by the fact that genetic modification of mature adipocytes is notoriously difficult. In this report, we evaluated the use of lentivirus-mediated gene transfer into 3T3-L1 mature adipocytes. We demonstrate that quiescent, fully differentiated 3T3-L1 adipocytes as well as 3T3-L1 preadipocytes can be efficiently transduced with HIV-1-derived lentiviral vectors. Upon transduction using LV-PGK-GFP lentiviral vector at 100 ng p24 per 10(5) cells, more than 95% of the 3T3-L1 adipocytes in the culture expressed the GFP reporter gene. There were no overt signs of toxicity or cytopathogenicity in the cultures. Furthermore, modification of undifferentiated preadipocytes did not affect their capacity to differentiate. In addition, insulin-induced glucose uptake was not affected by the procedure. In contrast, adenoviral-mediated gene transfer into 3T3-L1 adipocytes is associated with marked cytopathogenicity. From these data, we conclude that lentiviral vectors are the gene-transfer system of choice for genetic modification of mature adipocytes. The availability of an efficient vector system may stimulate the use of adipose tissue as a target for gene therapy in obesity and other disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14759805     DOI: 10.1016/j.ymthe.2003.11.021

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  57 in total

1.  Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire.

Authors:  Menno van Lummel; Peter A van Veelen; Arnaud Zaldumbide; Arnoud de Ru; George M C Janssen; Antonis K Moustakas; George K Papadopoulos; Jan W Drijfhout; Bart O Roep; Frits Koning
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

2.  Mesenchymal stem cells or cardiac progenitors for cardiac repair? A comparative study.

Authors:  Remco Koninckx; Annick Daniëls; Severina Windmolders; Françoise Carlotti; Urbain Mees; Paul Steels; Jean-Luc Rummens; Marc Hendrikx; Karen Hensen
Journal:  Cell Mol Life Sci       Date:  2010-10-24       Impact factor: 9.261

Review 3.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

Review 4.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

5.  Dendritic peptide bolaamphiphiles for siRNA delivery to primary adipocytes.

Authors:  Alexander C Eldredge; Mark E Johnson; Yang Cao; Lin Zhang; Can Zhao; Zhengxia Liu; Qin Yang; Zhibin Guan
Journal:  Biomaterials       Date:  2018-04-16       Impact factor: 12.479

6.  Dissecting the mechanism of insulin resistance using a novel heterodimerization strategy to activate Akt.

Authors:  Yvonne Ng; Georg Ramm; David E James
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

7.  Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth.

Authors:  Julia Schultz; Dirk Koczan; Ulf Schmitz; Saleh M Ibrahim; Dominik Pilch; Jenny Landsberg; Manfred Kunz
Journal:  Clin Exp Metastasis       Date:  2010-02-24       Impact factor: 5.150

8.  Glycine enhances expression of adiponectin and IL-10 in 3T3-L1 adipocytes without affecting adipogenesis and lipolysis.

Authors:  Jingqing Chen; Xiaoshi Ma; Ying Yang; Zhaolai Dai; Zhenlong Wu; Guoyao Wu
Journal:  Amino Acids       Date:  2018-01-22       Impact factor: 3.520

Review 9.  Gene therapy for pituitary tumors.

Authors:  Adriana Seilicovich; Daniel Pisera; Sandra A Sciascia; Marianela Candolfi; Mariana Puntel; Weidong Xiong; Gabriela Jaita; Maria G Castro
Journal:  Curr Gene Ther       Date:  2005-12       Impact factor: 4.391

10.  EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail.

Authors:  Bryan D Griffin; Anna M Gram; Arend Mulder; Daphne Van Leeuwen; Frans H J Claas; Fred Wang; Maaike E Ressing; Emmanuel Wiertz
Journal:  J Immunol       Date:  2013-01-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.